The earlier analyze (31) (N=fifty six patients) located higher levels of retrospectively assessed acute strain disorder symptoms and present-day PTSD symptoms among the patients who acquired enantiomer esketamine, compared with individuals who acquired racemic ketamine or opioids; the racemic ketamine group also confirmed mildly elevated acute anxi